Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease (NCT07060547)
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.
Who can join: Review the eligibility criteria below.
Location: Stanford University Dept. of Medicine -Gastroenterology & Hepatology โ Redwood City, California
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Stanford University Dept. of Medicine -Gastroenterology & Hepatology โ Redwood City, California
๐ Contact the Study Coordinator
Phone: (650) 460-6119
Email: eakamaga@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alcoholic Hepatitis
- Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis โ Cleveland, Ohio
- HA35 Moderate Alcoholic Hepatitis (AH) Study โ Cleveland, Ohio
- Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis โ Houston, Texas
Explore by condition: All Alcoholic Hepatitis clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.